Compare · CRON vs NAII
CRON vs NAII
Side-by-side comparison of Cronos Group Inc. (CRON) and Natural Alternatives International Inc. (NAII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CRON and NAII operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CRON is the larger of the two at $1.03B, about 62.1x NAII ($16.5M).
- Over the past year, CRON is up 46.4% and NAII is down 10.3% - CRON leads by 56.7 points.
- CRON has been more active in the news (3 items in the past 4 weeks vs 1 for NAII).
- CRON has more recent analyst coverage (11 ratings vs 0 for NAII).
- Company
- Cronos Group Inc.
- Natural Alternatives International Inc.
- Price
- $2.68+3.47%
- $2.71-1.09%
- Market cap
- $1.03B
- $16.5M
- 1M return
- +2.29%
- +0.00%
- 1Y return
- +46.45%
- -10.26%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 3
- 1
- Recent ratings
- 11
- 0
Cronos Group Inc.
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Natural Alternatives International Inc.
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
Latest CRON
- SEC Form DEFA14A filed by Cronos Group Inc.
- SEC Form DEF 14A filed by Cronos Group Inc.
- Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026
- SEC Form 4 filed by Shlimak Anna
- Officer Doucet Terrence Gregory Joseph converted options into 23,897 shares and covered exercise/tax liability with 12,276 shares, increasing direct ownership by 12% to 105,190 units (SEC Form 4)
- Officer Weigensberg Arye converted options into 24,236 shares, increasing direct ownership by 13% to 208,437 units (SEC Form 4)
- Officer Gorenstein Michael Ryan converted options into 324,540 shares and covered exercise/tax liability with 127,706 shares, increasing direct ownership by 2% to 13,213,017 units (SEC Form 4)
- Officer Shlimak Anna converted options into 45,226 shares and covered exercise/tax liability with 16,354 shares, increasing direct ownership by 9% to 339,933 units (SEC Form 4)
- Chief Growth Officer Jacobson Jeffrey David converted options into 59,191 shares and covered exercise/tax liability with 22,552 shares, increasing direct ownership by 8% to 484,681 units (SEC Form 4)
- Officer Buggy Shannon covered exercise/tax liability with 9,202 shares and converted options into 20,938 shares, increasing direct ownership by 8% to 166,879 units (SEC Form 4)
Latest NAII
- CarnoSyn® Brands Launches CarnoSyn® 4X, a Next-Generation Beta-Alanine for Sports Performance
- Natural Alternatives International Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by Natural Alternatives International Inc.
- SEC Form 4 filed by Natural Alternatives International Inc.
- President, COO, & Sec. Wolf Kenneth covered exercise/tax liability with 5,151 shares and was granted 15,000 shares, increasing direct ownership by 7% to 141,831 units (SEC Form 4)
- Director Dunn Alan G was granted 8,000 shares, increasing direct ownership by 9% to 99,211 units (SEC Form 4)
- Director Matherly Laura Kay was granted 8,000 shares, increasing direct ownership by 24% to 42,000 units (SEC Form 4)
- Director Ramanathan Guru was granted 8,000 shares, increasing direct ownership by 27% to 38,000 units (SEC Form 4)
- CEO/Chairman Ledoux Mark A bought $3,474 worth of shares (1,250 units at $2.78), increasing direct ownership by 0.79% to 160,221 units (SEC Form 4)
- CEO/Chairman Ledoux Mark A bought $2,820 worth of shares (1,000 units at $2.82), increasing direct ownership by 0.63% to 158,971 units (SEC Form 4)